elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38857067-45E208E4-F058-488B-A4E7-0ABFF6618361
Q38857067-45E208E4-F058-488B-A4E7-0ABFF6618361
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38857067-45E208E4-F058-488B-A4E7-0ABFF6618361
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
P478
Q38857067-45E208E4-F058-488B-A4E7-0ABFF6618361
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38857067-45E208E4-F058-488B-A4E7-0ABFF6618361
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ba48a87575df746b335220ef14fe310f4082e9c2
P478
30
http://www.w3.org/2001/XMLSchema#string